The genomes of long-living, big-brained mammal species reveal that they carry more copies of immunity genes. Experts ...

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies.

The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid ...

Colorectal cancer is the third most diagnosed type of cancer worldwide. Up to 80% of the cases are related to environmental ...

Manchester University's annual Student Symposium, showcasing undergraduate and graduate scholarly work across disciplines, was April 23.

Nutshell Therapeutics Inc. has synthesized deuterated indolizine compounds acting as cellular tumor antigen p53 (TP53) (Y220C mutant) reactivators reported to be useful for the treatment of cancer.

Co. Ltd. has received IND clearance from the FDA to initiate a phase I trial in the U.S. with NTS-071 for anticipated use in solid tumors with a p53 Y220C mutation. The trial is expected to begin in ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

In mice with human Merkel cell carcinoma, pyrvinium pamoate significantly reduced tumor growth, potentially offering a new ...

We are investigating the mechanisms by which cancer mutations deregulate the normal processes of cellular function and growth ...

Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...

Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key ...